Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim vs daily filgrastim for chemotherapy-induced neutropenia and PBPC mobilization in children
2005-002136-10Phase 3Completed
- Sponsor
- Istituto Giannina Gaslini
- Start
- Jun 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of pegfilgrastim in chemotherapy-induced neutropenia (CIN) (2 arms), sponsored by Istituto Giannina Gaslini. Started Jun 2005; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on 2005-002136-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002136-10.